Entry Detail



General Information

Database ID:exR0359218
RNA Name:ABCC1
RNA Type:mRNA
Chromosome:chr16
Starnd:+
Coordinate:
Start Site(bp):15949577End Site(bp):16143074
External Links:ENSG00000103222



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
TMED2
chr12
123584533
123598582
+
PCDHGB6
chr5
141408021
141512979
+
ADGRV1
chr5
90529344
91164437
+
CENPU
chr4
184694085
184734130
-
RFC5
chr12
118013588
118033130
+
BLVRB
chr19
40447765
40465764
-
MACF1
chr1
39081316
39487177
+
RPS5
chr19
58386400
58394806
+
SETD1A
chr16
30957754
30984664
+
CRTC3
chr15
90529923
90645345
+
PCDHGB1
chr5
141350102
141512979
+
PCDHGA8
chr5
141390157
141512979
+
NUCKS1
chr1
205712822
205750182
-
MT-ND4
chrMT
10760
12137
+
ASXL1
chr20
32358330
32439319
+
STRBP
chr9
123109500
123268586
-
UBE2S
chr19
55399745
55407788
-
ZDHHC4
chr7
6577434
6589374
+
NOP53
chr19
47745546
47757058
+
CD52
chr1
26317958
26320523
+
PSMB9
chr6
32844136
32859851
+
PCDHGA7
chr5
141382739
141512975
+
MT-CYB
chrMT
14747
15887
+
MT-ND5
chrMT
12337
14148
+
PCDHGA6
chr5
141373914
141512979
+
PCDHGA5
chr5
141364232
141512979
+
EIF4G2
chr11
10797050
10808940
-
MT-CO2
chrMT
7586
8269
+
SC5D
chr11
121292681
121313410
+
AC104109.3
chr5
134167170
134226071
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AD000090.1
chr19
35557956
35581954
+
AL136419.1
chr14
23969931
24051377
+
AC138932.3
chr16
14909887
14911345
-
ERVK13-1
chr16
2660348
2682379
-
GAS5
chr1
173858559
173868882
-
MIR663AHG
chr20
26167817
26251546
-
SNHG17
chr20
38419638
38435409
-
SNHG19
chr16
2154797
2155358
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.